Brief: Galera Announces FDA Acceptance And Priority Review Of Avasopasem NDA

Obsidian Therapeutics

15/02/2023 14:00

Feb 15 (Reuters) - Galera Therapeutics Inc  GRTX.O :
    * GALERA ANNOUNCES FDA ACCEPTANCE AND PRIORITY REVIEW OF
AVASOPASEM NDA FOR RADIOTHERAPY-INDUCED SEVERE ORAL MUCOSITIS
    * GALERA THERAPEUTICS INC - PDUFA TARGET DATE OF AUGUST 9,
2023

Source text for Eikon:  ID:nGNX1xhqhN 
Further company coverage:  GRTX.O 
 ((Reuters.briefs@thomsonreuters.com;))